Skip to content
Screener

Chemed CHE Segment Vitas — Depreciation

Other segment segments

Segment Roto Rooter
$8.3M+1.5%

Similar metrics at other companies

Best Buy logo
BBYDomestic Segment — Depreciation
$182M-9.5%
Concentrix Corporation logo
CNXCReportable Segment — Depreciation
$58.06M+3.4%
HF Foods Group Inc. logo
HFFGOperating Segment — Depreciation
$3.58M+23.9%
Medifast logo
MEDOptavia Segment — Depreciation
$2.6M+13.0%
Backblaze, Inc. logo
BLZEReportable Segment — Depreciation
$3.75M-28.6%
Lifecore Biomedical, Inc. logo
LFCRReportable Segment — Depreciation
$2.52M—

Other financials

Income statement

See full
Revenue$673.3M+8.8%
Gross profit$221.5M+19.9%
Operating income$89.2M+31.0%
Net income$67.7M+29.0%
EPS (diluted)$5.13+43.7%

Balance sheet

See full
Cash & equivalents$40.2M-83.9%
Total debt$181.3M+24.5%
Total equity$830.5M-30.7%
Total assets$1.6B-8.0%

Cash flow

See full
Operating cash flow$84.8M-38.8%
CapEx$15.5M-1.8%
Free cash flow$69.3M-43.6%

Valuation

See full
Market cap$7.18B+14.9%
Enterprise value$7.32B+19.1%
P/E26.1×+4.6×
P/S2.8×+0.3×

Profitability

See full
Gross margin33.1%-0.5pp
Operating margin13.5%-1.2pp
Net margin10.6%-1.0pp
FCF margin12.5%-2.3pp

Returns & leverage

See full
Return on equity27.1%+3.0pp
Debt / equity0.2×+0.1×
Current ratio0.9×-1.0×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The source filing: Chemed’s 10-Q, filed April 28, 2026.

Filed
Apr 28, 2026, 9:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000019584-26-000012
Line itemVITASRoto-RooterReportable / SegmentsCorporateChemed / Consolidated
Stock compensation---10,75410,754
Other expenses8,87323,00431,8774,84936,726
Total selling, general and administrative expense26,10967,92994,03820,283114,321
Depreciation5,9128,37914,2911214,303
Amortization262,5442,570-2,570
Other operating (income)/expense52(60)(8)-(8)
Total costs and expenses357,566195,074552,64020,295572,935
Income/(loss) from operations62,45242,421104,873(20,295)84,578

Item 1. Financial Statements

FAQ

What is Chemed's segment vitas — depreciation?
Chemed (CHE) reported segment vitas — depreciation of $5.91M in Q1 2026.
How has Chemed's segment vitas — depreciation changed year-over-year?
Chemed's segment vitas — depreciation increased by 13.8% year-over-year, from $5.2M to $5.91M.
What is the long-term trend for Chemed's segment vitas — depreciation?
Over 3 years (2022 to 2025), Chemed's segment vitas — depreciation has grown at a -1.0% compound annual growth rate (CAGR), from $21.96M to $21.31M.
What does segment vitas — depreciation mean?
The systematic allocation of the cost of tangible assets over their useful lives within the hospice segment. This non-cash expense reflects the wear and tear of medical equipment, facilities, and other physical infrastructure. It is a key component in reconciling cash flow from operations and assessing capital intensity.

Ask your AI about Chemed's segment vitas — depreciation.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude